首页 › 基金 › Patient Square Capital LP › IVA
Patient Square Capital LP 对 IVA 的持仓历史
INVENTIVA SA · 医疗保健
Patient Square Capital LP 在 Q3 2026 的 13F 申报中披露持有 IVA(INVENTIVA SA)1,221,225 股,市值约 US$4.5M,约占其申报组合的 0.72%,在其申报持仓中市值排名第 22 位。 Patient Square Capital LP 最近 2 个申报季度中有 2 个季度披露了 IVA 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Patient Square Capital LP 对 IVA 的持仓演变
Patient Square Capital LP 于 Q2 2026 首次披露 IVA 持仓:1,967,171 股(约 US$7.4M)。 在 2 次申报中,Patient Square Capital LP 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 1,221,225 股、市值约 US$4.5M,环比减持 -745,946 股。。 持仓曾出现大幅变动:Q3 2026 减持约 38% (随后一个季度股价基本持平)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 1.97M | $7.44M | 新进 |
| Q3 2026 | 1.22M | $4.51M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 IVA 与 13F 数据
IVA(INVENTIVA SA)属于医疗保健行业。我们追踪的基金中还有 88 只申报持有 IVA,申报仓位最大的包括:Caligan Partners LP (US$30.9M), Samsara BioCapital, LLC (US$23.9M), Paradigm Biocapital Advisors LP (US$15.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 IVA 的基金
- Caligan Partners LP 8.16M 股 · $30.86M · Q2 2026
- Samsara BioCapital, LLC 6.31M 股 · $23.87M · Q2 2026
- Paradigm Biocapital Advisors LP 4.00M 股 · $15.12M · Q2 2026
- ADAR1 Capital Management, LLC 3.61M 股 · $13.63M · Q2 2026
- Andera Partners 3.63M 股 · $13.41M · Q3 2026
- SymBiosis Capital Partners, LLC 2.35M 股 · $13.06M · Q1 2026
- Trails Edge Capital Partners, LP 2.66M 股 · $10.05M · Q2 2026
- Squadron Capital Management LLC 2.44M 股 · $9.20M · Q2 2026
- NEXTBio Capital Management LP 1.79M 股 · $6.60M · Q3 2026
- Yu Fan 1.50M 股 · $5.67M · Q2 2026
- NEA Management Company, LLC 1.46M 股 · $5.53M · Q2 2026
- STEMPOINT CAPITAL LP 1.43M 股 · $5.39M · Q2 2026
更多关于 Patient Square Capital LP
常见问题
How long has Patient Square Capital LP held IVA?
Patient Square Capital LP has disclosed IVA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Patient Square Capital LP's current position in IVA?
As of Q3 2026, Patient Square Capital LP holds 1.22M shares of IVA (INVENTIVA SA), valued at $4.51M, representing 0.72% of its reported portfolio and ranking #22.
Has Patient Square Capital LP been buying or selling IVA?
In the latest 13F filing (Q3 2026), Patient Square Capital LP reduced its position in IVA.
Which other funds hold IVA?
Other major institutional holders of IVA include Caligan Partners LP, Samsara BioCapital, LLC, Paradigm Biocapital Advisors LP, among 88 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.